MedPath

Hartmut Malluche Md

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

4

Active:0
Completed:2

Trial Phases

2 Phases

Phase 4:2
Not Applicable:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials

Phase 4
2 (66.7%)
Not Applicable
1 (33.3%)

Precision Medicine Approach for Osteoporosis - Follow Up Study

Phase 4
Conditions
Osteoporosis
Interventions
First Posted Date
2024-02-20
Last Posted Date
2025-04-08
Lead Sponsor
Paul F Netzel
Target Recruit Count
40
Registration Number
NCT06264609
Locations
🇺🇸

University of Kentucky, Lexington, Kentucky, United States

Novel Precision Medicine Approach to Treatment of Osteoporosis Based on Bone Turnover

Phase 4
Recruiting
Conditions
Age-Related Osteoporosis
Interventions
First Posted Date
2021-12-09
Last Posted Date
2025-04-24
Lead Sponsor
Madhumathi Rao
Target Recruit Count
60
Registration Number
NCT05151484
Locations
🇺🇸

University of Kentucky, Lexington, Kentucky, United States

Renal Osteodystrophy: An Individual Management Approach

Not Applicable
Completed
Conditions
Kidney Failure, Chronic
Interventions
First Posted Date
2015-05-12
Last Posted Date
2023-01-05
Lead Sponsor
Hartmut Malluche, MD
Target Recruit Count
141
Registration Number
NCT02440581
Locations
🇺🇸

University of Kentucky, Lexington, Kentucky, United States

Renal Osteodystrophy: A Fresh Approach

Completed
Conditions
Renal Osteodystrophy
First Posted Date
2009-03-11
Last Posted Date
2017-05-05
Lead Sponsor
Hartmut Malluche, MD
Target Recruit Count
464
Registration Number
NCT00859612
Locations
🇺🇸

University of Kentucky, Lexington, Kentucky, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.